52 drugs were stopped and 8000 hospitals strictly controlled "best selling drugs"

52 drugs were stopped and 8000 hospitals strictly controlled "best selling drugs" On December 5, the national health and Health Commission released the notice on strengthening the performance appraisal of secondary public hospitals, and 2020 launched the performance appraisal of secondary public hospitals nationwide The assessment of the second level hospital is a continuation of the assessment of the third level hospital launched at the beginning of the year According to the number of national medical and health institutions by the end of September 2018 released by the national health and Health Commission on November 20, 2018, there were 8714 secondary hospitals by the end of September 2018 The assessment of more than 8000 hospitals includes 28 indicators, including the use intensity of antibacterial drugs, the proportion of the amount of winning drugs in the centralized purchase of drugs organized by the state, and the proportion of the income of key monitoring drugs The national drug market will change greatly In the published performance evaluation indicators of secondary public hospitals (Trial), it is a precise blow to this kind of drugs to require hospitals to fill in the proportion of income of key monitoring drugs Among them, 20 varieties of national version have been "best-selling" in many hospitals According to statistics, at present, Inner Mongolia, Heilongjiang, Guangdong, Jiangsu, Sichuan, Shaanxi, Guizhou, Gansu, Jilin, Hubei, Yunnan, Fujian and other provinces (autonomous regions) have published key monitoring directories According to the requirements of the notice on further promoting the experience of deepening the reform of medical and health system in Fujian Province and Sanming City issued by the leading group of deepening the reform of medical and health system of the State Council on November 15, by the end of December 2019, each province shall formulate and issue the catalogue of key drugs for monitoring and rational use of drugs at the provincial level (chemical drugs and biological products) and publish it By the end of December 2020, key drug monitoring shall be established in an all-round way Mechanism It can be predicted that, with the publication of the provincial catalogue and the assessment of the second and third level hospitals, the use of the key monitored varieties will be squeezed across the country According to the observation of some pharmaceutical enterprises, the enterprises whose products are mainly monitored have rapidly started the transformation, and these monitored drugs are no longer the future of enterprises In fact, according to the industry news recently, some hospitals have temporarily cleared out the supply catalogue of some key monitoring drugs According to the official account of WeChat public, a large three grade hospital in Shandong issued the first batch of "list of drugs for basic drug supply list" It is reported that a total of 52 drugs were discharged from the hospital's basic drug supply list The main list of the withdrawal lists was injections, including 37 injections, and some key national monitoring varieties One explanation is that the three-level hospital assessment was launched at the beginning of the year, and the hospital temporarily stopped using some drugs under the pressure of indicators towards the end of the year; the other may be that the hospital received the pressure of medical insurance funds In any case, these varieties are increasingly being treated coldly in hospitals It can be imagined that after the second level hospital assessment is fully launched next year, it is more likely that the key monitored drugs will be temporarily stopped or simply abandoned According to the assessment procedure released by the national health and Health Commission, this is a normal work The second level hospital is required to complete the analysis and evaluation of the hospital performance in the previous year before the end of August 020, and complete the above work before the end of March 2021 Appendix: performance evaluation indicators of secondary public hospitals (Trial)